Tag Archive for: omics

Neurology

Spanish Ferrer SA pays €122.5m for ALS candidate

Spanish Ferrer Internacional, SA has aquired the ex-US rights to VRG50635 from Verge Genomics Inc to commercialise the oral Phase I experimental ALS treatment.

Read more